Watch Drs. Garcia-Manero & Roboz discuss #MDS - https://bit.ly/3C2IdSb
Watch Drs. Garcia-Manero & DeZern discuss #MDS updates from #SOHO2024 - https://bit.ly/MDSHouston24Y
Drs. Garcia-Manero & DeZern discuss #MDS at #SOHO23 - https://bit.ly/MDSHouston23Y
Drs. Garcia-Manero, Khoury, & Savona discuss #MDS at #ASH22 - http://bit.ly/3Hk19yC
Drs. Garcia-Manero, Komrokji, & Shastri discuss #MDS during #ASCO23 - https://bit.ly/3Nee4oB
Combining Hypomethylation Drugs and Immune Check Point Inhibitors - G Garcia-Manero
Meet leukemia oncologist Guillermo Garcia-Manero, M.D.
Keynote Presentation - Incorporating genomic information in the treatment of MDS
The association between mutations and comorbidities in patients with MDS
Management of treatment-naïve LR-MDS
Building Personalized MDS Management Plans
Leukemia Highlights from the 2018 American Society of Hematology, with Guillermo Garcia-Manero, MD
Myelodysplastic Syndromes | Exploring Current Considerations and Promising Investigational Approa...
Expert Perspectives: MPN and MDS
Exploring Current Considerations and Promising Investigational Approaches for Patients with Myelo...
Promising results in MDS for ASTX727, an oral decitabine and cytidine deaminase inhibitor agent
A Unified Approach to Lower Risk MDS: Standard and Emerging Therapies
My approach to MDS management
Real-world treatment patterns of patients with low-risk MDS reinitiating ESAs
Managing and Treating MDS